IL181185A - Composition containing polymorphs a, b and c of azabicyclohexane, said polymorphs, process for their preparation and pharmaceutical compositions containing them - Google Patents
Composition containing polymorphs a, b and c of azabicyclohexane, said polymorphs, process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL181185A IL181185A IL181185A IL18118507A IL181185A IL 181185 A IL181185 A IL 181185A IL 181185 A IL181185 A IL 181185A IL 18118507 A IL18118507 A IL 18118507A IL 181185 A IL181185 A IL 181185A
- Authority
- IL
- Israel
- Prior art keywords
- polymorph
- polymorph form
- acid addition
- azabicyclo
- addition salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92074804A | 2004-08-18 | 2004-08-18 | |
PCT/US2005/029420 WO2006023659A2 (en) | 2004-08-18 | 2005-08-17 | Novel polymorphs of azabicyclohexane |
Publications (2)
Publication Number | Publication Date |
---|---|
IL181185A0 IL181185A0 (en) | 2007-07-04 |
IL181185A true IL181185A (en) | 2012-10-31 |
Family
ID=35968183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL181185A IL181185A (en) | 2004-08-18 | 2007-02-06 | Composition containing polymorphs a, b and c of azabicyclohexane, said polymorphs, process for their preparation and pharmaceutical compositions containing them |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1786417A4 (pt) |
JP (1) | JP2008510715A (pt) |
KR (3) | KR20130108489A (pt) |
CN (1) | CN101052393A (pt) |
AU (1) | AU2005277351A1 (pt) |
BR (1) | BRPI0515193A (pt) |
CA (1) | CA2619817A1 (pt) |
IL (1) | IL181185A (pt) |
MX (1) | MX2007001827A (pt) |
NO (1) | NO20071372L (pt) |
NZ (1) | NZ589033A (pt) |
RU (1) | RU2007109817A (pt) |
WO (1) | WO2006023659A2 (pt) |
ZA (1) | ZA200701570B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070043100A1 (en) | 2005-08-16 | 2007-02-22 | Hagen Eric J | Novel polymorphs of azabicyclohexane |
EP1915146A4 (en) | 2005-07-27 | 2010-06-02 | Dov Pharmaceutical Inc | NOVEL 1-ARYL-3-AZABICYCLO [3.1.0] HEXANEES. PREPARATION AND USE FOR THE TREATMENT OF NEUROPSYCHIATRIC DISEASES |
US20080045725A1 (en) * | 2006-04-28 | 2008-02-21 | Murry Jerry A | Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane |
US8138377B2 (en) | 2006-11-07 | 2012-03-20 | Dov Pharmaceutical, Inc. | Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use |
US9133159B2 (en) | 2007-06-06 | 2015-09-15 | Neurovance, Inc. | 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments |
EP2646019A4 (en) * | 2010-12-03 | 2014-05-21 | Euthymic Bioscience Inc | PREPARATION AND USE OF (+) - 1- (3,4-DICHLOROPHENYL) -3-AZABICYCLO- [3.1.0] HEXANE IN THE TREATMENT OF DISEASES AFFECTED BY MONOAMINE-TYPE NEUROTRANSMITTERS |
US20140206740A1 (en) | 2011-07-30 | 2014-07-24 | Neurovance, Inc. | Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters |
WO2014182279A1 (en) * | 2013-05-07 | 2014-11-13 | Euthymics Bioscience, Inc. | Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive and alcohol-related disorders |
KR101567003B1 (ko) | 2013-12-27 | 2015-11-06 | 경희대학교 산학협력단 | 골편 고정장치 및 골편 절단을 위한 드릴 어셈블리 |
SG10201911417PA (en) | 2015-06-17 | 2020-01-30 | Otsuka America Pharmaceutical Inc | Crystalline compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4435419A (en) * | 1981-07-01 | 1984-03-06 | American Cyanamid Company | Method of treating depression using azabicyclohexanes |
US6372919B1 (en) * | 2001-01-11 | 2002-04-16 | Dov Pharmaceutical, Inc. | (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent |
-
2005
- 2005-08-17 WO PCT/US2005/029420 patent/WO2006023659A2/en active Application Filing
- 2005-08-17 KR KR1020137024105A patent/KR20130108489A/ko not_active Application Discontinuation
- 2005-08-17 ZA ZA200701570A patent/ZA200701570B/xx unknown
- 2005-08-17 MX MX2007001827A patent/MX2007001827A/es active IP Right Grant
- 2005-08-17 JP JP2007528015A patent/JP2008510715A/ja active Pending
- 2005-08-17 KR KR1020077006293A patent/KR20070054208A/ko not_active Application Discontinuation
- 2005-08-17 EP EP05785506A patent/EP1786417A4/en not_active Withdrawn
- 2005-08-17 KR KR1020127030289A patent/KR20130004370A/ko not_active Application Discontinuation
- 2005-08-17 NZ NZ589033A patent/NZ589033A/en not_active IP Right Cessation
- 2005-08-17 CA CA002619817A patent/CA2619817A1/en not_active Abandoned
- 2005-08-17 BR BRPI0515193-7A patent/BRPI0515193A/pt not_active IP Right Cessation
- 2005-08-17 CN CNA2005800279269A patent/CN101052393A/zh active Pending
- 2005-08-17 AU AU2005277351A patent/AU2005277351A1/en not_active Abandoned
- 2005-08-17 RU RU2007109817/04A patent/RU2007109817A/ru not_active Application Discontinuation
-
2007
- 2007-02-06 IL IL181185A patent/IL181185A/en not_active IP Right Cessation
- 2007-03-14 NO NO20071372A patent/NO20071372L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1786417A4 (en) | 2009-05-20 |
NO20071372L (no) | 2007-05-18 |
JP2008510715A (ja) | 2008-04-10 |
RU2007109817A (ru) | 2008-09-27 |
CN101052393A (zh) | 2007-10-10 |
KR20130004370A (ko) | 2013-01-09 |
AU2005277351A1 (en) | 2006-03-02 |
KR20070054208A (ko) | 2007-05-28 |
MX2007001827A (es) | 2007-04-23 |
WO2006023659A3 (en) | 2006-12-07 |
WO2006023659A2 (en) | 2006-03-02 |
KR20130108489A (ko) | 2013-10-02 |
CA2619817A1 (en) | 2006-03-02 |
EP1786417A2 (en) | 2007-05-23 |
BRPI0515193A (pt) | 2008-07-08 |
ZA200701570B (en) | 2008-08-27 |
IL181185A0 (en) | 2007-07-04 |
NZ589033A (en) | 2012-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9770436B2 (en) | Polymorphs of azabicyclohexane | |
IL181185A (en) | Composition containing polymorphs a, b and c of azabicyclohexane, said polymorphs, process for their preparation and pharmaceutical compositions containing them | |
US20070082938A1 (en) | Polymorphs of bicifadine hydrochloride | |
US20070149599A1 (en) | Polymorphs of bicifadine hydrochloride | |
EP1087976A1 (fr) | Forme polymorphe de l'hydrogenosulfate de clopidogrel | |
EP1939176A1 (en) | Salts of Tegaserod | |
JPH09510222A (ja) | 2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピン化合物の酸付加塩 | |
AU2012203400B2 (en) | Novel polymorphs of azabicyclohexane | |
US6387925B1 (en) | Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions | |
WO2023225773A1 (en) | Solid forms of mesembrine and therapeutic uses thereof | |
AU2020213989B2 (en) | Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound | |
AU2015200286B2 (en) | Polymorphic forms st-246 and methods of preparation | |
KR20240116208A (ko) | 결정형의 미라베그론 신규염, 이의 제조방법 및 이를 포함하는 약학적 조성물 | |
AU2001100432A4 (en) | Process for making amlodipine maleate | |
KR20100101405A (ko) | 비결정형의 (+)-란소프라졸 제조방법 및 이에 사용되는 (+)-란소프라졸 알코올레이트 | |
EP1713769B1 (en) | Amorphous tamsulosin hydrochloride | |
KR20070116188A (ko) | 5-[4-[2-[엔-메틸-엔-(2-피리딜)아미노]에톡시]벤질]티아졸리딘 4-디온 말레이트의 신규의 다형상 및 그제조방법 | |
KR20070113328A (ko) | 5-[4-[2-[엔-메틸-엔-(2-피리딜)아미노]에톡시]벤질]티아졸리딘 4-디온 말레이트의 신규의 다형상 및 그제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |